13.10
+0.17(+1.31%)
Currency In USD
| Previous Close | 12.93 |
| Open | 13.04 |
| Day High | 13.56 |
| Day Low | 12.99 |
| 52-Week High | 17.43 |
| 52-Week Low | 4.68 |
| Volume | 2.46M |
| Average Volume | 2.31M |
| Market Cap | 977.9M |
| PE | 16.79 |
| EPS | 0.78 |
| Moving Average 50 Days | 12.45 |
| Moving Average 200 Days | 10.64 |
| Change | 0.17 |
If you invested $1000 in CorMedix Inc. (CRMD) 10 years ago, it would be worth $916.08 as of August 18, 2025 at a share price of $13.1. Whereas If you bought $1000 worth of CorMedix Inc. (CRMD) shares 5 years ago, it would be worth $2,706.61 as of August 18, 2025 at a share price of $13.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
GlobeNewswire Inc.
Aug 07, 2025 11:00 AM GMT
Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potentialTransaction expected to be near-ter
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
GlobeNewswire Inc.
Jun 27, 2025 12:00 PM GMT
BERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced the pri
CorMedix Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Jun 26, 2025 8:01 PM GMT
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it